RxDoctor Payments Data

Denise Fried, PA

Physician Assistant · Bismarck, NDNPI 1740254739

Payments from drug & device makers

$571in general payments, 2019–2025

Across 31 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$160
  • Lundbeck LLC$82
  • Johnson & Johnson$73
  • Neurocrine Biosciences, Inc.$69
  • Lexicon Pharmaceuticals, Inc.$60
  • Acadia Pharmaceuticals Inc$43
  • plus $84 from 4 others

What the payments were for

  • Food & beverage$571100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$571 in reported general payments places this provider in the 70th percentile of 355 physician assistant providers in North Dakota.

See all physician assistant providers in North Dakota

Medicare billing

Part B allowed, 2024
$96,643
Medicare patients
284
Services billed
1,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban281$76,511
MyrbetriqMirabegron167$28,569
XifaxanRifaximin17$26,657
XareltoRivaroxaban61$16,792
MounjaroTirzepatide13$14,820
JanuviaSitagliptin Phosphate34$10,389
NamzaricMemantine Hcl/Donepezil Hcl23$6,782
Gabapentin299$6,388
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$6,217
GemtesaVibegron25$6,120
BelsomraSuvorexant12$5,693
FarxigaDapagliflozin Propanediol19$5,557
AbrysvoRsv Vacc, Pref A And Pref B/Pf17$5,417
RocklatanNetarsudil Mesylat/Latanoprost14$5,165
Pantoprazole Sodium196$5,064

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$17$81,928298 claims
Astellas Pharma US IncMyrbetriq$160$28,569167 claims
Johnson & JohnsonXarelto$73$16,79261 claims
Lilly USA, LLCMounjaro$35$14,82013 claims
Boehringer IngelheimStiolto Respimat, Jardiance$18$9,91124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 355 physician assistant providers in North Dakota.

Other physician assistant in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →